Oncology drug discovery is thriving, but with so many potential cancer treatments in development, recruiting patients for clinical trials represents a significant challenge.
Mass spectrometry has developed rapidly to
become an important analytical technique.
However, application to the analysis of
biological specimens was at first limited
because the ionization processes could only
be applied to compounds of low molecular
weight, and the instrument interfaces did ...
When clinical trials were first developed to test the effectiveness of drugs in treating diseases, it was usual to carry out tests using multiple drug samples, including for pharmacokinetics (PK) and other assessments such as pharmacodynamics (PD). Samples were taken individually, and the time ...
As the biopharmaceutical industry is facing a longer, more complex,
and more expensive drug development process, all stakeholders must
demonstrate flexibility and the ability to innovate and find solutions
to overcome challenges. Patient recruitment for clinical trials that are
well managed ...
Influenza vaccination plays an important role in reducing the severity of flu epidemics and reducing the disease burden caused by seasonal influenza.
The first FDA-approved therapeutic monoclonal antibody (mAb) was muromonab in 1986, and since then, numerous mAb drugs have been approved, and many more are in the later stages of clinical development. In the main, mAbs are being developed against immunological and oncological targets, but their ...